AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
For BancFirst, the core belief for shareholders is that a conservatively run regional bank can keep translating disciplined credit underwriting and steady profitability into reliable earnings and dividends over time. The latest quarter’s higher net income and EPS, alongside net charge-offs falling to US$2.4 million from US$4.7 million a year earlier, supports that narrative by pointing to healthier loan performance. In the short term, that cleaner credit picture may ease some concern around asset quality, but it does not really change the bigger swing factors: how BancFirst manages growth while trading on a relatively full earnings multiple, and whether it can sustain returns that lag faster growing peers. The muted share price reaction so far suggests the news is helpful, but not transformative for those risks and catalysts.
However, one underwriting slip or credit shock could quickly challenge that improving charge off trend. BancFirst's shares have been on the rise but are still potentially undervalued by 35%. Find out what it's worth.Explore another fair value estimate on BancFirst - why the stock might be worth as much as 7% more than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com